tezspire
astrazeneca ab - tezepelumab - asma - medicamentos para obstrutiva, doenças das vias respiratórias, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
imjudo
astrazeneca ab - tremelimumab - carcinoma, hepatocellular - agentes antineoplásicos - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
arimidex
astrazeneca do brasil ltda - anastrozol - antineoplasico
atacand hct
astrazeneca do brasil ltda - candesartana cilexetila, hidroclorotiazida - anti-hipertensivos
brilinta
astrazeneca do brasil ltda - ticagrelor - antiagregante plaquetario
calquence
astrazeneca do brasil ltda - acalabrutinibe - inibidores da proteÍna quinase; agentes antineoplÁsicos
crestor
astrazeneca do brasil ltda - rosuvastatina cálcica - antilipemicos
daxas
astrazeneca do brasil ltda - roflumilaste - outros produtos para o aparelho respiratorio
esomeprazol magnésio triidratado
astrazeneca do brasil ltda - esomeprazol magnésico tri-hidratado - antiulcerosos
fasenra
astrazeneca do brasil ltda - benralizumabe - outros antialergicos